Franck Griscelli

Frank Griscelli is Professor of Biotherapy at Paris Descartes University, Doctor of Pharmacy and Doctor of Science. He has been researching for 23 years in research units (INSERM / CNRS) in the field of medical oncology. Since 1997, he has been director of the virology laboratory of the Gustave-Roussy Institute (Villejuif) and has been responsible for the patient monitoring laboratory included in gene therapy clinical trials in relation with several industrial promoters (Transgene, Aventis & Cobra Therapeutics). He also created and developed an insurance and quality control laboratory in the American subsidiary of Rhône Mérieux (Athens, GA, USA) specializing in the field of anti-infective vaccines. He is currently an investigator in the Inserm U935 unit and works on different projects in the field of cell therapy by using embryonic stem cells and induced pluripotent stem cells as well. He is involved in the development of tissue bio engineering by using different sources of progenitors (liver, breast, pancreas kidney) for future medical applications.